(19)
(11) EP 1 156 067 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.10.2008 Bulletin 2008/42

(45) Mention of the grant of the patent:
05.12.2007 Bulletin 2007/49

(21) Application number: 01111835.3

(22) Date of filing: 16.05.2001
(51) International Patent Classification (IPC): 
C08F 220/28(2006.01)
C08F 220/60(2006.01)
C08L 33/14(2006.01)
 C08F 220/34(2006.01)
A61M 1/34(2006.01)

(54)

Blood filter with (meth)acrylic copolymers comprising glycolether and aminoalkyl units

Blutfilter mit (Meth)Acrylcopolymerisate enthaltend Glykolether- und Aminoalkyl-Einheiten

Filtre à sang comprenant des copolymères (meth)acrylique contenant des segments de glycoléther et aminoalcoyle

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 17.05.2000 JP 2000145386

(43) Date of publication of application:
21.11.2001 Bulletin 2001/47

(73) Proprietor: TERUMO KABUSHIKI KAISHA
Tokyo (JP)

(72) Inventors:
  • Tanaka, Masaru
    Sapporo-shi, Hokkaido (JP)
  • Tokunaga, Norifumi c/o Terumo Kabushiki Kaisha
    Kanagawa (JP)

(74) Representative: TBK-Patent 
Bavariaring 4-6
80336 München
80336 München (DE)


(56) References cited: : 
EP-A- 0 420 765
WO-A-84/00621
US-A- 4 218 554
 EP-A- 0 469 196
GB-A- 1 198 052
US-A- 4 981 936
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).